Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing

NCT03433833 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study Not Funded

Conditions

Polycythemia; Familial
Erythrocytosis; Familial
VHL Gene Mutation
HIF-2alpha Erythrocytosis
PHD2 Erythrocytosis
Chuvash Erythrocytosis

Interventions

DRUG: Digoxin

Sponsor

University of Illinois at Chicago